60 related articles for article (PubMed ID: 1302570)
1. A prospective study of hprt mutant and mutation frequencies in treated cancer patients.
Caggana M; Liber HL; Coleman CN; Mauch P; Clark JR; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 1992; 1(7):573-80. PubMed ID: 1302570
[TBL] [Abstract][Full Text] [Related]
2. Mutagenesis after cancer therapy.
Kelsey KT; Caggana M; Mauch PM; Coleman CN; Clark JR; Liber HL
Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):177-84. PubMed ID: 8143613
[TBL] [Abstract][Full Text] [Related]
3. A new T-lymphocyte cloning assay for detection of in vivo mutations in the human hypoxanthine-guanine phosphoribosyltransferase gene.
Uematsu K; Yasuda J; Sekine T; Sugano K; Kudoh S; Sekiya T
Environ Mol Mutagen; 1997; 30(1):31-9. PubMed ID: 9258327
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of mutant frequencies at the hprt and T-cell receptor gene loci in pediatric cancer patients during chemotherapy.
Sawada M; Kubota M; Lin YW; Watanabe K; Koishi S; Usami I; Akiyama Y; Matsumura T; Furusho K
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):711-7. PubMed ID: 9718224
[TBL] [Abstract][Full Text] [Related]
5. Mutagenesis after therapy for Hodgkin's disease.
Kelsey KT; Caggana-Aviles M; Mauch P; Coleman CN; Shulman LN; Liber HL
Hematol Oncol Clin North Am; 1993 Apr; 7(2):353-67. PubMed ID: 8468270
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
Meng Q; Su T; O'Neill JP; Walker VE
Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
[TBL] [Abstract][Full Text] [Related]
7. Analysis of microsatellite instability in children treated for acute lymphocytic leukemia with elevated HPRT mutant frequencies.
Kendall HE; Vacek PM; Finette BA
Mutagenesis; 2004 Sep; 19(5):409-12. PubMed ID: 15388815
[TBL] [Abstract][Full Text] [Related]
8. Analysis of genetic alterations and clonal proliferation in children treated for acute lymphocytic leukemia.
Kendall HE; Vacek PM; Rivers JL; Rice SC; Messier TL; Finette BA
Cancer Res; 2006 Sep; 66(17):8455-61. PubMed ID: 16951156
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of the frequencies and molecular spectra of HPRT mutants when human cancer cells were X-irradiated during G1 or S phase.
Leonhardt EA; Trinh M; Forrester HB; Johnson RT; Dewey WC
Radiat Res; 1997 Dec; 148(6):548-60. PubMed ID: 9399700
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte Hprt mutant frequency and sperm toxicity in C57BL/6 mice treated chronically with Azathioprine.
Bendre SV; Shaddock JG; Patton RE; Dobrovolsky VN; Albertini RJ; Heflich RH
Mutat Res; 2005 Oct; 578(1-2):1-14. PubMed ID: 16107271
[TBL] [Abstract][Full Text] [Related]
11. Mutation frequency and spectrum in lymphocytes of small cell lung cancer patients receiving etoposide chemotherapy.
Karnaoukhova L; Moffat J; Martins H; Glickman B
Cancer Res; 1997 Oct; 57(19):4393-407. PubMed ID: 9331103
[TBL] [Abstract][Full Text] [Related]
12. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
13. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
[TBL] [Abstract][Full Text] [Related]
14. Myelin basic protein peptide specificity and T-cell receptor gene usage of HPRT mutant T-cell clones in patients with multiple sclerosis.
Lodge PA; Allegretta M; Steinman L; Sriram S
Ann Neurol; 1994 Nov; 36(5):734-40. PubMed ID: 7526775
[TBL] [Abstract][Full Text] [Related]
15. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.
Finette BA; Poseno T; Albertini RJ
Cancer Res; 1996 Mar; 56(6):1405-12. PubMed ID: 8640832
[TBL] [Abstract][Full Text] [Related]
16. DNA sequence analysis of hprt mutants persisting in peripheral blood of cynomolgus monkeys more than two years after ENU treatment.
Harbach PR; Mattano SS; Zimmer DM; Filipunas AL; Wang Y; Aaron CS
Environ Mol Mutagen; 1999; 33(1):42-8. PubMed ID: 10037322
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
18. The L84F polymorphism in the O6-Methylguanine-DNA-Methyltransferase (MGMT) gene is associated with increased hypoxanthine phosphoribosyltransferase (HPRT) mutant frequency in lymphocytes of tobacco smokers.
Hill CE; Wickliffe JK; Guerin AT; Kinslow CJ; Wolfe KJ; Ammenheuser MM; Abdel-Rahman SZ
Pharmacogenet Genomics; 2007 Sep; 17(9):743-53. PubMed ID: 17700363
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing mutation at the hprt locus in T-lymphocytes: women treated for breast cancer.
Branda RF; O'Neill JP; Sullivan LM; Albertini RJ
Cancer Res; 1991 Dec; 51(24):6603-7. PubMed ID: 1742733
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of HPRT mutant frequency in children with cancer.
Rice SC; Vacek PM; Homans AH; Kendall H; Rivers J; Messier T; Finette BA
Environ Mol Mutagen; 2003; 42(1):44-9. PubMed ID: 12874812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
